Hypertension and activation of the renin–angiotensin system may have driven this rise in ACE2 in order to counterbalance system effects of infection, and future studies should include blood pressure evaluation in conjunction with other clinical parameters such as oxygen saturation, chemistry panels, and imaging. The gene discussed is ACE2; the disease is Hypertension.